PAR 7.32% 22.0¢ paradigm biopharmaceuticals limited..

Ann: Global Market Research indicates price for Zilosu, page-26

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,425 Posts.
    lightbulb Created with Sketch. 6967
    Yeah hard to believe its not $3 plus...I agree...but some reasons could be the fact that I know the science...YOU know the science and the potential...but they do not.

    Who are they?

    Outsiders, people that have never heard of PAR...they have some spare cash to invest BUT how do they know we are the real deal?

    Have they talked to the patients that post on here?
    Have they talked to other patients outside of HC, the footballers, the SAS patients?
    Have they read just any one of the peer reviewed publications?
    Have they done any comparison between competition and us?
    Do they know about MPS studies and trials that are going on....wait, do they know what MPS even stands for?
    What is their understanding of OA and what are the current remedies?
    Do they even know who Dr Krishanan is? How it works and what AE's there have been?
    Do they have a spare couple of years to wait if they know all the above? Do they even know whats to come? What are the next few stages?
    What is the relevance between synovial inflammatory markers and our drug and a world first regressive remedy in this OA realm?


    To them, what indeed is the difference between PAR, OCC, OSX and a number of others just on the Aussie stock exchange.

    There are not many that still know about us or have done the research. Most are lazy and will either not do the research for themsevles, if anything they will just rely on someone else...when it moves it might attract their attention, when they finally hear about it in the papers they might check out the chart and see that it has gone from $4 to $2 and think, nah - pass.

    What will it take for them to understand our potential. In the same way CSL...it was very slow and flat to start with, its only after revenue started growing and growing and they expanded into other markets did it attract any sort of mass market attention....Aggressive Revenue Growth...ARG...increasing multiples, year on year...

    This will change for us...but it will be some time perhaps...yes we are also some way off in terms of timetables, more data and of course eventual revenue and more proof of how we differ from anything else. Yes a meaningful deal will change all this, we don't know when that will happen, could be in a few months, could be an entire year away, perhaps a bit more?

    Do not get frustrated by the share price being lower than it 'should' be, a total disconnect. Just my views, the glory is not now (though we are on a beautiful path now that IND is open, that is a major win for us all)...it is still some time away, as I have always maintained, hold....hold.....hold ... ..do not be tempted to sell out and move. We are so much more informed that the rest out there (my views)....

    Last edited by Mozzarc: 08/11/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.015(7.32%)
Mkt cap ! $76.98M
Open High Low Value Volume
21.0¢ 22.5¢ 21.0¢ $242.2K 1.102M

Buyers (Bids)

No. Vol. Price($)
1 16020 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 310000 2
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.